[EN] PHYTOSPHINGOSINE DERIVATIVES AS ADJUVANTS IN IMMUNE STIMULATION<br/>[FR] DÉRIVÉS DE PHYTOSPHINGOSINE SERVANT D'ADJUVANTS DANS LA STIMULATION IMMUNITAIRE
申请人:HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH
公开号:WO2021255287A1
公开(公告)日:2021-12-23
The invention relates to phytosphingosine derivatives, suitable as adjuvants in immune stimulation. The invention further relates to pharmaceutical compositions comprising such compounds and the medical use of said compounds and/or compositions in therapeutic or prophylactic methods of immune stimulation in a subject, and for use in the treatment of a disease, for which stimulation of an immune response in a subject produces a therapeutic benefit. The invention further relates to the phytosphingosine derivative as described herein for use as an adjuvant in a method of vaccinating a subject. The invention further relates to the phytosphingosine derivative as described herein for use in stimulating antibody production, stimulating an immune response against infection, stimulating an immune response against a cancer, or preventing and/or treating septic shock. The invention further relates to a method for the manufacture of said derivatives comprising an Ugi-4-component reaction (Ugi-4CR).
该发明涉及植物鞘氨醇衍生物,适用于免疫刺激的辅助剂。该发明还涉及包含这些化合物的药物组合物,以及所述化合物和/或组合物在治疗或预防免疫刺激方法中的医疗用途,用于治疗疾病,对于在受试者中刺激免疫反应产生治疗益处的用途。该发明还涉及所述植物鞘氨醇衍生物用作接种受试者的辅助剂的方法。该发明还涉及所述植物鞘氨醇衍生物用于刺激抗体产生,刺激抗感染免疫反应,刺激抗癌免疫反应,或预防和/或治疗感染性休克的方法。该发明还涉及一种制备所述衍生物的方法,包括Ugi-4组分反应(Ugi-4CR)。